CervoMed Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CervoMed Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q3 2024.
  • CervoMed Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 8.25M shares, a 45.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.25M +2.58M +45.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 8.25M +6.21M +305% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 6.17M +4.13M +202% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 5.67M +5.16M +995% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 5.67M +3.64M +178% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.04M +1.37K +0.07% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 2.04M +1.63K +0.08% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 518K -1.52M -74.6% Dec 31, 2022 10-K 2024-03-29
Q3 2022 2.04M -99.9M -98% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 2.04M -99.9M -98% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 2.04M -99.9M -98% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 2.04M -62M -96.8% Dec 31, 2021 10-K 2023-03-24
Q3 2021 102M +37.9M +59.2% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 102M +37.9M +59.2% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 102M +67.3M +194% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 64M +30.5M +91.2% Dec 31, 2020 10-K 2022-03-18
Q3 2020 64M +59.3M +1264% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 64M +59.3M +1264% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 34.6M +31.2M +925% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 33.5M +30.1M +892% Dec 31, 2019 10-K 2021-03-17
Q3 2019 4.69M -45.9M -90.7% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 4.69M -45.9M -90.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 3.38M -47.2M -93.3% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 3.38M +2.41M +249% Dec 31, 2018 10-K 2020-03-17
Q3 2018 50.6M +36.1M +249% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 50.6M +38.3M +313% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 50.5M +40.2M +388% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 968K -9.38M -90.6% Dec 31, 2017 10-K 2019-03-19
Q3 2017 14.5M +4.16M +40.2% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 12.2M -91.2M -88.2% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 10.3M -92.1M -89.9% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 10.3M +2.23M +27.4% Dec 31, 2016 10-K 2018-04-02
Q3 2016 10.3M -8.27M -44.4% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 103M +84.8M +456% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 102M +83.8M +450% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 8.12M -10.5M -56.4% Dec 31, 2015 10-K 2017-03-31
Q3 2015 18.6M +109K +0.59% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 18.6M +224K +1.22% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 18.6M +9.93M +114% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 18.6M +12.8M +220% Dec 31, 2014 10-K 2016-03-25
Q3 2014 18.5M -402M -95.6% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 18.4M -70.7M -79.4% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 8.68M -81.8M -90.4% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 5.81M +4.92M +553% Dec 31, 2013 10-K 2015-04-03
Q3 2013 421M +331M +366% Sep 30, 2013 10-Q 2013-11-19
Q2 2013 89.1M +927K +1.05% Jun 30, 2013 10-Q 2013-11-19
Q1 2013 90.5M Mar 31, 2013 10-Q/A 2013-05-20
Q4 2012 891K -87.3M -99% Dec 31, 2012 10-K 2016-03-25
Q3 2012 90.3M +12.4M +16% Sep 30, 2012 10-Q 2012-11-19
Q2 2012 88.2M +23.9M +37.2% Jun 30, 2012 10-Q/A 2012-09-07
Q4 2011 88.2M +24M +37.5% Dec 31, 2011 10-K/A 2013-04-24
Q3 2011 77.9M Sep 30, 2011 10-Q 2011-11-21
Q2 2011 64.3M Jun 30, 2011 10-Q 2011-08-16
Q4 2010 64.1M Dec 31, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.